Updated Aug 11
Nov 10, 2026
Anthropic Launches Claude Fable 5.2 With 20% Price Cut Ahead of IPO
Anthropic released Claude Fable 5.2 and Mythos 5.2 on Monday, claiming the top spot on 13 of 15 benchmark score lines against GPT-6 Astra and Gemini 4 Carbon. The new models are 30% faster and 20% cheaper than their predecessors, priced at $8 per million input tokens — undercutting OpenAI's flagship. The launch comes days before Anthropic's blockbuster IPO and marks its first frontier release since CEO Dario Amodei called for a slowdown in AI development.
anthropicclaude-fable-5-2claude-mythos-5-2
Nov 9, 2026
OpenAI, Google, Microsoft, and Anthropic Back Unified AI Training Opt-Out in Robots.txt
The four largest Western AI labs will honor a single robots.txt policy token that lets website owners opt out of AI training across all their crawlers at once. Anthropic has already begun implementation; OpenAI, Google, and Microsoft follow in 2027.
robots-txtai-trainingweb-crawlers
Nov 8, 2026
Elvis Estate and Eminem Publisher Sue Suno in Escalating AI Music Copyright War
The rights holders for Elvis Presley and Eminem's publisher Eight Mile Style filed separate federal lawsuits against AI music generator Suno on Friday, alleging copyright infringement and violations of Tennessee's ELVIS Act. The twin filings mark one of the first major tests of the 2024 voice-cloning law and escalate an already intense legal battle between the music industry and AI companies.
sunoai-musiccopyright
Related News
Apr 27, 2026
Microsoft & OpenAI's Breakup: New Freedom, New Risks
Microsoft and OpenAI have overhauled their partnership, ending Microsoft's exclusive rights to OpenAI's tech. The non-exclusive deal frees OpenAI to team up with other cloud providers. This shift impacts Microsoft's positioning in the AI space and could spur wider AI adoption.
MicrosoftOpenAIpartnership
Apr 24, 2026
AI Missteps in Healthcare: Lessons From Benjamin Riley's Story
Benjamin Riley's recount of his father's reliance on a flawed AI-generated medical report highlights the dangers of AI in healthcare. Dr. Adam Kittai and Dr. David Bond reveal the report was "nonsense," posing fatal risks. AI's misguided advice emphasizes the need for cautious AI applications, especially in medical circumstances.
AIhealthcaremisinformation
Apr 24, 2026
OpenAI Shifts Focus Amid Fierce Competition: Inside Sam Altman's Strategic Pivot
OpenAI, pressured by rivals like Anthropic and Google, trims non-core projects to boost financial discipline. Under Sam Altman's leadership, the company concentrates on monetizable AI tools amid IPO plans. The challenge: balancing innovation with revenue demands.
OpenAISam AltmanAnthropic